Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Cash Flow Quality Index
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Cash Flow Quality Index of 0.11x as of December 2023. Operating cash flow of CN¥26.95 Million is below net income of CN¥243.07 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Xinxiang Tuoxin Pharmaceutical Co.Ltd. cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow Quality Index (2019–2023)
Historical Cash Flow Quality Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Xinxiang Tuoxin Pharmaceutical Co.Ltd. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2023)
Year-by-year earnings quality comparison for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. For live market cap and the full company financial profile, see Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.11x | CN¥26.95 Million | CN¥243.07 Million | ▼ -88.2% |
| 2022 | 0.94x | CN¥268.85 Million | CN¥286.54 Million | ▲ +5.9% |
| 2021 | 0.89x | CN¥58.19 Million | CN¥65.71 Million | ▼ -16.8% |
| 2020 | 1.06x | CN¥120.00 Million | CN¥112.80 Million | ▼ -24.6% |
| 2019 | 1.41x | CN¥86.38 Million | CN¥61.25 Million | — |